Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Other Non-Current Assets: 2019-2022

Historic Other Non-Current Assets for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $902,000.

  • ADC Therapeutics' Other Non-Current Assets rose 13.79% to $1.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $1.0 million, marking a year-over-year increase of 13.79%. This contributed to the annual value of $902,000 for FY2022, which is 30.16% up from last year.
  • As of FY2022, ADC Therapeutics' Other Non-Current Assets stood at $902,000, which was up 30.16% from $693,000 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Other Non-Current Assets ranged from a high of $902,000 in FY2022 and a low of $368,000 during FY2019.
  • Over the past 2 years, ADC Therapeutics' median Other Non-Current Assets value was $797,500 (recorded in 2021), while the average stood at $797,500.
  • Data for ADC Therapeutics' Other Non-Current Assets shows a peak YoY surged of 30.16% (in 2022) over the last 5 years.
  • ADC Therapeutics' Other Non-Current Assets (Yearly) stood at $368,000 in 2019, then reached $693,000 in 2021, then spiked by 30.16% to $902,000 in 2022.